BUZZ - Reports say EchoStar is in talks with SpaceX regarding its Boost Mobile business, causing its stock price to surge.
路透社2026/11/02 11:56November 2 - ** Telecom company EchoStar (ECHO.O) saw its share price rise by 4.6% in pre-market trading, reaching $101.44
** According to The Washington Post, SpaceX SPCX.O is in talks to acquire EchoStar's wireless service provider Boost Mobile or to obtain rights to use its network. The network is currently leased by EchoStar from AT&T T.N and T-Mobile TMUS.O (link)
** The share prices of T-Mobile and AT&T fell by nearly 2% and 1%, respectively
** SPCX and ECHO have not yet responded to Reuters' requests for comment
** According to data compiled by London Stock Exchange Group (LSEG), all eight brokers covering ECHO have rated it "buy" or higher; its median target price is $130
** As of the close of the previous trading day, ECHO has declined by 10.82% so far this year
(To assist non-native English speakers, Reuters provides automated translation of its reporting into several other languages. Automated translation may contain errors or may not include necessary context, so Reuters does not guarantee the accuracy of automated translation. It is provided solely for reader convenience. Reuters does not accept any liability for any harm or loss arising from the use of automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Trump Media & Technology Group plunges over 24%, hitting a new low since listing.
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.